NCT04822181: An ongoing trial by Novo Nordisk A/S
This trial is ongoing. It must report results 5 years, 8 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT04822181 |
|---|---|
| Title | The Effect of Semaglutide in Subjects With Non-cirrhotic Non-alcoholic Steatohepatitis |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 1, 2021 |
| Completion date | June 1, 2029 |
| Required reporting date | June 1, 2030, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Feb. 9, 2024 |
| Days late | None |